Overview

A Phase I/IIa Clinical Study to Assess the Single and Multiple Ascending Doses of MDR-001 Tablets in Healthy Participants and Obese/ Overweight Participants

Status:
RECRUITING
Trial end date:
2025-12-30
Target enrollment:
Participant gender:
Summary
To investigate the safety and tolerability after single and multiple ascending doses of MDR-001 Tablets administered orally in healthy participants and obese/ overweight participants.
Phase:
PHASE1
Details
Lead Sponsor:
MindRank AI Ltd